Quantification of increased biologically active CXCL12α plasma concentrations after ACKR3 antagonist treatment in humans por Peter Blattmann, Hervé Farine, Brian Dan, Nicole Stiffler, Thomas Lefebvre, Christine Huynh, Patricia N. Sidharta, Jasper Dingemanse, Richard W. D. Welford, Marcel Keller, Daniel S. Strasser

Enlace del recurso